News
AstraZeneca Pill Cut Risk of Breast Cancer Death, Study Finds
Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could change the way such cancers are treated,
AstraZeneca unveils drug to treat mutating breast cancer before it starts to grow
AstraZeneca has unveiled positive trial results for a breast cancer drug that can stop mutating tumours before they start to grow, hoping it will be one of a portfolio of medicines that will propel it to become the world leader in oncology.
Two studies reveal promising treatments for breast cancer, enhancing options for patients with triple-negative breast cancer ...
MedPage Today on MSN2d
First-Line Keytruda-Trodelvy Boosts PFS in Triple-Negative Breast CancerCombining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment ...
Meanwhile, BioNTech itself bought into the category with its takeover of BNT327's developer Biotheus unit last year for what ...
A new pre-surgery treatment strategy for inherited breast cancer has achieved an astonishing 100% survival rate, thanks to a ...
Despite being more likely to be diagnosed with triple negative breast cancer (TNBC), Black women remain underrepresented in ...
The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study ...
First-line treatment with sacituzumab govitecan plus pembrolizumab showed significant improvement in PFS vs. chemotherapy ...
From antibody-drug conjugates to PARP inhibitors, innovative treatments are offering new hope for patients with ...
The oncology giant will pay $1.5 billion to co-develop a BioNTech drug that targets the proteins PD1 and VEGF, following ...
Epidemiologist Christine Ambrosone spoke about her work at the annual lecture named for the UB faculty member who helped ...
The Independent on MSN5d
Mother who beat breast cancer discovers years later disease has moved to brain during ‘vertigo’ treatmentMother who beat breast cancer discovers years later disease has moved to brain during ‘vertigo’ treatment - Carrie Howard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback